Trial Profile

A clinical trial of Merimepodib alone in the outpatient setting

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 25 Sep 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Merimepodib (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use

Most Recent Events

22 Sep 2020 According to a BioSig Technologies media release, this trial will be initiated after the completion of the current Phase 2 combination trial.
21 May 2020 New trial record
14 May 2020 According to a ViralClea media release, this trial in the outpatient setting with just merimepodib is proposed to follow the initiation of the first trial.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com